Lynn Cancer Center

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Head and neck cancer

Closed trials

• Recruiting

  Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

  NCT05283226· Phase 2· NATCO Pharma Ltd.· Source

  Contact: Praveen Myneni, MBBS